A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral tablet that combines two current HIV treatment medications – bictegravir and ...
At CROI 2026, experts warned that missing HBV screening risks reactivation during HIV therapy switches.
US President's Emergency Plan for AIDS Relief (PEPFAR), the global HIV response has entered a second year of structural ...
A new study has overcome a long-standing challenge: how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease ...
Because of last weekend's huge Hopkins-Wright pay-per-view, almost all of the media overlooked an excellent New York Times article by John Eligon and Duff Wilson, by far the most comprehensive piece I ...
BURLINGTON, N.C., Feb. 11, 2026 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® pTau ...
LAS VEGAS (KTNV) — The Southern Nevada Health District stopped by the new West Las Vegas Library on Saturday to offer testing for HIV and Hepatitis C. Officials say the goal of events like this is to ...
NORTH CHARLESTON, S.C. (WCIV) — National Black HIV/AIDS Awareness Day will be observed Saturday, Feb. 7, with local health advocates urging education, testing and stigma reduction to address the ...
Adding laboratory-based HIV viral load (VL) test results — with a median turnaround time of 26 hours — to standard-of-care testing did not improve overall linkage to care compared with ...
Abstract: This paper investigates the decision-making solutions for enterprise product quality inspection based on sequential testing and genetic algorithms. Firstly, using the binomial distribution ...
Abstract: This paper aims to enhance the efficiency and precision of intelligent algorithm evaluations and to advance the standardization of testing and evaluation processes. By dissecting the testing ...